Addex Therapeutics Ltd (ADXN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CHF
| Market Cap | 6.21M |
| Enterprise Value | 4.61M |
| P/E Ratio | -0.73 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 68.48 |
| Price/Book Ratio | 2.1 |
| Enterprise/Revenue | 59.18 |
| Enterprise/EBITDA | -1.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -77.75 |
| Operating Margin | -30 |
| Return On Assets | -1.46 |
| Return On Equity | -1.31 |
| Revenue | 173,000 |
| Revenue/Share | 0 |
| Gross Profit | 164,388 |
| EBITDA | -2.82M |
| Net Income | -6.73M |
| Diluted EPS | -0.06 |
| Total Cash | 937,500 |
| Total Cash/Share | 0.01 |
| Total Debt | 102,269 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 0.97 |
| Book Value Per Share | 0.02 |
| 52-Week Change | -31.76 |
| 52-Week High | 0.09 |
| 52-Week Low | 0.03 |
| Moving Average 50 Days | 0.04 |
| Moving Average 200 Days | 0.05 |
| Average Volume | 180,358 |
| Shares Outstanding | 151.9M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |